|
C16ORF63 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.86020018569877E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.80944148553408E-12 |
| Normal-vs-Stage2 |
9.641800E-03 |
| Normal-vs-Stage3 |
6.165900E-02 |
| Normal-vs-Stage4 |
6.088200E-02 |
| Stage1-vs-Stage2 |
4.295400E-01 |
| Stage1-vs-Stage3 |
1.245220E-04 |
| Stage1-vs-Stage4 |
1.317320E-03 |
| Stage2-vs-Stage3 |
1.523000E-01 |
| Stage2-vs-Stage4 |
2.005200E-01 |
| Stage3-vs-Stage4 |
8.744200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.34460031786921E-10 |
| Normal-vs-AfricanAmerican |
3.633600E-02 |
| Normal-vs-Asian |
3.700800E-01 |
| Caucasian-vs-AfricanAmerican |
2.119400E-01 |
| Caucasian-vs-Asian |
5.896600E-01 |
| AfricanAmerican-vs-Asian |
9.542400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.99000000103922E-08 |
| Normal-vs-Female |
1.86069999963401E-07 |
| Male-vs-Female |
3.962800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.852600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.78020000249657E-08 |
| Normal-vs-Age(61-80Yrs) |
1.28579999980616E-07 |
| Normal-vs-Age(81-100Yrs) |
1.643780E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.154200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.722000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.754000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.189200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.883200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.051400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.798200E-03 |
| Normal-vs-Grade 2 |
7.95474797143925E-13 |
| Normal-vs-Grade 3 |
7.54640000000251E-05 |
| Normal-vs-Grade 4 |
5.482400E-01 |
| Grade 1-vs-Grade 2 |
2.246200E-01 |
| Grade 1-vs-Grade 3 |
3.043300E-03 |
| Grade 1-vs-Grade 4 |
6.35059999999354E-05 |
| Grade 2-vs-Grade 3 |
2.973800E-04 |
| Grade 2-vs-Grade 4 |
1.33699999960157E-08 |
| Grade 3-vs-Grade 4 |
9.552600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
2.273600E-01 |
| ccA subtype-vs-ccB subtype |
3.78586051397178E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.33250000109587E-08 |
| Normal-vs-N1 |
4.220400E-01 |
| N0-vs-N1 |
2.541100E-03 |
|
|
